Results 141 to 150 of about 34,583 (288)
Minimizing the risk of macrosomia
Journal of the Chinese Medical Association, 2023 Yang, Szu-Ting +2 more
openaire +2 more sources
Citation: 'macrosomia' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.10912 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire +1 more source
Diabetic Medicine, EarlyView.Abstract Aims To investigate the clinical use, in early pregnancy in women living with type 1 diabetes (T1D), of automated insulin delivery (AID) systems lacking pregnancy‐specific algorithms and to evaluate the maternal and glycaemic outcomes associated with their implementation in routine care. Methods This observational study included women with T1D
Sara Hallström +2 more
wiley +1 more source
Medicentro, 2011 Se realizó un estudio retrospectivo descriptivo longitudinal del comportamiento de la macrosomía fetal en el servicio de Obstetricia del Hospital General Docente "Enrique Cabrera", durante el período de mayo de 2002 a abril de 2003, con el ...
José Antonio Marrero Martínez +5 more
doaj
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Background Gestational diabetes mellitus (GDM) complicates roughly one in seven pregnancies and predicts later maternal type 2 diabetes mellitus (T2DM). Yet its pharmacological management still rests on a handful of agents (insulin, metformin and glibenclamide), none of them selected on the basis of the disease's molecular genetics.
Wael Osman
wiley +1 more source
Glycaemic Management and Pregnancy Outcomes in HNF1A‐MODY
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Introduction Birthweight of HNF1A‐affected offspring is largely similar to the background population with rarely reported cases of large for gestational age (LGA) and neonatal hypoglycaemia (NH). Conventional clinical management of pre‐gestational diabetes appears to be sufficient in managing HNF1A‐affected women in pregnancy.
M. T. Crowley +10 more
wiley +1 more source
Prediction of fetal macrosomia using two-dimensional and three-dimensional ultrasound
, 2019 The estimation of the fetal weight by three-dimensional (3D) ultrasound (US) with fractional thigh volume (TVol) has been suggested to be more accurate than two-dimensional (2D) US particularly within the context of fetuses at risk of macrosomia.
Frusca T. +6 more
core +1 more source
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Background and Aims Metformin is increasingly used to treat gestational diabetes mellitus and other insulin‐resistant conditions during pregnancy. Because it crosses the placenta, concerns remain regarding its potential effects on offspring growth and metabolic programming.
Otilia Perichart‐Perera +2 more
wiley +1 more source
Novel epigenetic link between gestational diabetes mellitus and macrosomia
, 2021 Background & objectives: Examine maternal gestational diabetes mellitus (GDM), macrosomia and DNA methylation in candidate genes IGF1, IGF2, H19, ARHGRF11, MEST, NR3C1, ADIPOQ and RETN. Materials & methods: A total of 1145 children (572 GDM cases and 573
Hou, Lifang +14 more
core
Journal of Diabetes Investigation, EarlyView.In this retrospective study of 537 Japanese women with GDM, underweight at age 20 and before pregnancy was associated with a lower risk of delivering a LGA infant. These historical weight factors may help stratify fetal growth risk, although underweight should not be encouraged because of potential small for gestational age and low‐birth‐weight risks ...
Shinya Furukawa +6 more
wiley +1 more source